Santé & Pharma

Foresight Acquisition Corp.

Forest Road Acquisition Corp.

Forian Inc.

68 M

Forma Therapeutics Holdings, Inc.

Formycon AG

336 M

Forte Biosciences, Inc.

899 M

Fortress Biotech, Inc.

107 M

Forza Innovations Inc

252 k

Frans Venker

Frans Venker

359 M

Fredun Pharma

14 Md

Fredun Pharma

15 Md

Frequency Therapeutics, Inc.

Fresenius Medical Care AG

11 Md

Fresenius SE & Co. KGaA

24 Md

Fulcrum Therapeutics, Inc.

233 M

Fulgent Genetics, Inc.

593 M

Fusion Pharmaceuticals Inc.

Future Health ESG Corp.

G1 Therapeutics, Inc.

GAROFALO HEALTH CARE

475 M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A. ACQUISISCE CASA DI CURA CITTA’ DI ROMA / GAROFALO HEALTH CARE S.P.A. ACQUIRES CASA DI CURA CITTA' DI ROMA

470 M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: ASSEMBLEA ORDINARIA E STRAORDINARIA DEGLI AZIONISTI / ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING

470 M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: IL CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 31 MARZO 2026 / BOARD OF DIRECTORS APPROVES INTERIM FINANCIAL REPORT AT MARCH 31, 2026

482 M

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: STANDARD ETHICS ALZA IL RATING DI SOSTENIBILITA' / STANDARD ETHICS RAISES SUSTAINABILITY RATING

GAROFALO HEALTH CARE GAROFALO HEALTH CARE S.P.A.: STANDARD ETHICS CONFERMA IL RATING ESG DI BREVE E MEDIO/LUNGO TERMINE / STANDARD ETHICS CONFIRMS SHORT-TERM AND MEDIUM/LONG-TERM ESG RATINGS

GAROFALO HEALTH CARE GHC ACQUISISCE LO STORICO GRUPPO ROMANO DA CUI HA TRATTO LE SUE ORIGINI / GHC ACQUIRES THE HISTORICAL ROMAN GROUP FROM WHICH IT DREW ITS ORIGINS

470 M

GAROFALO HEALTH CARE SPA

482 M

GBS Inc.

GBS Inc.

GC메디아이

151 Md

GDR

7,1 M

GENFIT

516 M

GENOMED S.A.

GENOWAY

28 M

GERON CORP

962 M

GLAUKOS Corp

9,1 Md

GMR Solutions Inc.

836 M

GRAIL, Inc.

3,3 Md

GRIFOLS, S.A

6,5 Md

GRIFOLS, S.A.

6,2 Md

GROUPE TERA

13 M

GSK plc

78 Md

GSS

83 M

GT Biopharma, Inc.

16 M

GUERBET

110 M

GVS GVS

GVS SPA

802 M

GW Pharmaceuticals PLC

Gabather AB

23 M